Clinical Trials Browser

Phase 1 × Brain Neoplasms × CTLA-4 Antigen × Clear all

NCT05341349 2025-07-30

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Phase 1 Active not recruiting

CNSDermatologic

Uveal Melanoma, Brain Neoplasms, Melanoma